Horie, A.; Miyagaki, T.; Hiranuma, C.; Iijima, M.; Hara, Y.; Oba, S.; Hashimoto, M.; Omori, R.; Okano, T.; Kadono, T.
Clinical Effectiveness, Clinical Stability, and Effects on Serum Galectin-7 Levels of Dupilumab and JAK Inhibitors in Moderate-to-Severe Atopic Dermatitis: A Real-World, Single-Center Analysis. Medicina 2025, 61, 926.
https://doi.org/10.3390/medicina61050926
AMA Style
Horie A, Miyagaki T, Hiranuma C, Iijima M, Hara Y, Oba S, Hashimoto M, Omori R, Okano T, Kadono T.
Clinical Effectiveness, Clinical Stability, and Effects on Serum Galectin-7 Levels of Dupilumab and JAK Inhibitors in Moderate-to-Severe Atopic Dermatitis: A Real-World, Single-Center Analysis. Medicina. 2025; 61(5):926.
https://doi.org/10.3390/medicina61050926
Chicago/Turabian Style
Horie, Akihiro, Tomomitsu Miyagaki, Chikako Hiranuma, Mami Iijima, Yoshiaki Hara, Shinya Oba, Mina Hashimoto, Reina Omori, Tatsuro Okano, and Takafumi Kadono.
2025. "Clinical Effectiveness, Clinical Stability, and Effects on Serum Galectin-7 Levels of Dupilumab and JAK Inhibitors in Moderate-to-Severe Atopic Dermatitis: A Real-World, Single-Center Analysis" Medicina 61, no. 5: 926.
https://doi.org/10.3390/medicina61050926
APA Style
Horie, A., Miyagaki, T., Hiranuma, C., Iijima, M., Hara, Y., Oba, S., Hashimoto, M., Omori, R., Okano, T., & Kadono, T.
(2025). Clinical Effectiveness, Clinical Stability, and Effects on Serum Galectin-7 Levels of Dupilumab and JAK Inhibitors in Moderate-to-Severe Atopic Dermatitis: A Real-World, Single-Center Analysis. Medicina, 61(5), 926.
https://doi.org/10.3390/medicina61050926
